We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Solicitor General, Generics Makers Rally Behind Sandoz in Biosimilar Case
Solicitor General, Generics Makers Rally Behind Sandoz in Biosimilar Case
The U.S. solicitor general, the biosimilar industry, and several generics makers have filed U.S. Supreme Court briefs in support of reversing a Federal Circuit ruling that orders sponsors to wait six months after an FDA approval to launch a biosimilar.